Ocular axial length
|
phenotype |
|
Clinical Attribute
|
4
|
11
|
0.100 |
None |
1.000 |
1 |
1
|
2013 |
2013 |
Late insomnia
|
phenotype |
Nervous System Diseases; Mental Disorders
|
Mental or Behavioral Dysfunction
|
4
|
1
|
0.010 |
None |
1.000 |
1 |
|
2009 |
2009 |
Advanced sleep phase
|
phenotype |
|
Disease or Syndrome
|
5
|
1
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Hyperthymic state
|
disease |
|
Mental or Behavioral Dysfunction
|
8
|
5
|
0.010 |
None |
1.000 |
1 |
2
|
2017 |
2017 |
Early Awakening
|
phenotype |
Nervous System Diseases; Mental Disorders
|
Mental or Behavioral Dysfunction
|
10
|
1
|
0.010 |
None |
1.000 |
1 |
|
2010 |
2010 |
Leishmania infantum disease
|
disease |
|
Disease or Syndrome
|
11
|
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Immune-complex glomerulonephritis
|
disease |
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Disease or Syndrome
|
12
|
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Filoviridae Infections
|
disease |
Infections
|
Disease or Syndrome
|
13
|
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |
Childhood atopic dermatitis
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Skin and Connective Tissue Diseases; Immune System Diseases
|
Disease or Syndrome
|
13
|
|
0.010 |
None |
1.000 |
1 |
|
2006 |
2006 |
Cholestasis-edema syndrome, Norwegian type
|
disease |
Digestive System Diseases; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
14
|
|
0.010 |
None |
1.000 |
1 |
|
2013 |
2013 |
Breast Fibrocystic Change, Proliferative Type
|
disease |
Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
14
|
|
0.010 |
None |
1.000 |
1 |
|
2004 |
2004 |
Pneumonia in children
|
disease |
|
Disease or Syndrome
|
15
|
3
|
0.010 |
None |
1.000 |
1 |
|
2020 |
2020 |
Atopic disorders
|
group |
|
Disease or Syndrome
|
29
|
2
|
0.010 |
None |
1.000 |
1 |
|
2007 |
2007 |
Lofgrens syndrome
|
disease |
Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
30
|
13
|
0.010 |
None |
1.000 |
1 |
|
2009 |
2009 |
Ovarian adenocarcinoma
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases
|
Neoplastic Process
|
43
|
1
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
[D]Sleep disturbances (& [hypersomnia] or [insomnia])
|
phenotype |
|
Sign or Symptom
|
69
|
23
|
0.010 |
None |
1.000 |
1 |
1
|
2016 |
2016 |
Community acquired pneumonia
|
disease |
Infections; Respiratory Tract Diseases
|
Disease or Syndrome
|
75
|
13
|
0.010 |
None |
1.000 |
1 |
|
2020 |
2020 |
Idiopathic crescentic glomerulonephritis
|
disease |
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Disease or Syndrome
|
80
|
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |
Hypotension, Orthostatic
|
phenotype |
Nervous System Diseases; Cardiovascular Diseases
|
Disease or Syndrome
|
82
|
21
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Pleurisy
|
disease |
Infections; Respiratory Tract Diseases
|
Disease or Syndrome
|
82
|
7
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Cytokine Measurement
|
phenotype |
|
Laboratory Procedure
|
82
|
123
|
0.100 |
None |
1.000 |
1 |
1
|
2012 |
2012 |
Bipolar I disorder
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
83
|
46
|
0.010 |
None |
1.000 |
1 |
|
2006 |
2006 |
MOHR-TRANEBJAERG SYNDROME
|
disease |
Pathological Conditions, Signs and Symptoms; Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Eye Diseases; Nervous System Diseases; Mental Disorders; Otorhinolaryngologic Diseases; Behavior and Behavior Mechanisms
|
Disease or Syndrome
|
89
|
19
|
0.010 |
None |
1.000 |
1 |
|
2000 |
2000 |
Cytokine storm
|
disease |
|
Disease or Syndrome
|
97
|
|
0.020 |
None |
1.000 |
2 |
|
2017 |
2019 |
Alveolar Bone Loss
|
disease |
Musculoskeletal Diseases; Stomatognathic Diseases
|
Disease or Syndrome
|
101
|
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |